These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

172 related items for PubMed ID: 15515430

  • 1. Structural analysis of human specific cytolysin intermedilysin aiming application to cancer immunotherapy.
    Ohkura K, Nagamune H, Kourai H.
    Anticancer Res; 2004; 24(5C):3343-53. PubMed ID: 15515430
    [Abstract] [Full Text] [Related]

  • 2. Molecular dynamics of human-specific cytolysin: analysis of membrane binding motif for therapeutic application.
    Ohkura K, Hori H, Nagamune H.
    Anticancer Res; 2006; 26(6A):4055-62. PubMed ID: 17195457
    [Abstract] [Full Text] [Related]

  • 3. Molecular profiles of cholesterol-dependent cytolysin family-derived 11mer regions.
    Ohkura K, Kawaguchi Y, Tabata A, Yamamoto A, Shinohara Y, Nagamune H, Hori H.
    Anticancer Res; 2012 Jun; 32(6):2343-6. PubMed ID: 22641672
    [Abstract] [Full Text] [Related]

  • 4. The cholesterol-dependent cytolysin family of gram-positive bacterial toxins.
    Heuck AP, Moe PC, Johnson BB.
    Subcell Biochem; 2010 Jun; 51():551-77. PubMed ID: 20213558
    [Abstract] [Full Text] [Related]

  • 5. Crystal structure of cytotoxin protein suilysin from Streptococcus suis.
    Xu L, Huang B, Du H, Zhang XC, Xu J, Li X, Rao Z.
    Protein Cell; 2010 Jan; 1(1):96-105. PubMed ID: 21204001
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The cholesterol-dependent cytolysin signature motif: a critical element in the allosteric pathway that couples membrane binding to pore assembly.
    Dowd KJ, Farrand AJ, Tweten RK.
    PLoS Pathog; 2012 Jan; 8(7):e1002787. PubMed ID: 22792065
    [Abstract] [Full Text] [Related]

  • 10. Characterization of recombinant Streptococcus mitis-derived human platelet aggregation factor.
    Ohkuni H, Nagamune H, Ozaki N, Tabata A, Todome Y, Watanabe Y, Takahashi H, Ohkura K, Kourai H, Ohtsuka H, Fischetti VA, Zabriskie JB.
    APMIS; 2012 Jan; 120(1):56-71. PubMed ID: 22151309
    [Abstract] [Full Text] [Related]

  • 11. Specificity of streptolysin O in cytolysin-mediated translocation.
    Meehl MA, Caparon MG.
    Mol Microbiol; 2004 Jun; 52(6):1665-76. PubMed ID: 15186416
    [Abstract] [Full Text] [Related]

  • 12. Profiles of ILY, VLY and Sm-hPAF interaction with human CD59.
    Kawaguchi Y, Tabata A, Nagamune H, Ohkura K.
    Anticancer Res; 2013 Jul; 33(7):2901-4. PubMed ID: 23780977
    [Abstract] [Full Text] [Related]

  • 13. The human-specific action of intermedilysin, a homolog of streptolysin O, is dictated by domain 4 of the protein.
    Nagamune H, Ohkura K, Sukeno A, Cowan G, Mitchell TJ, Ito W, Ohnishi O, Hattori K, Yamato M, Hirota K, Miyake Y, Maeda T, Kourai H.
    Microbiol Immunol; 2004 Jul; 48(9):677-92. PubMed ID: 15383705
    [Abstract] [Full Text] [Related]

  • 14. Cellular functions and X-ray structure of anthrolysin O, a cholesterol-dependent cytolysin secreted by Bacillus anthracis.
    Bourdeau RW, Malito E, Chenal A, Bishop BL, Musch MW, Villereal ML, Chang EB, Mosser EM, Rest RF, Tang WJ.
    J Biol Chem; 2009 May 22; 284(21):14645-56. PubMed ID: 19307185
    [Abstract] [Full Text] [Related]

  • 15. Specific protein-membrane contacts are required for prepore and pore assembly by a cholesterol-dependent cytolysin.
    Soltani CE, Hotze EM, Johnson AE, Tweten RK.
    J Biol Chem; 2007 May 25; 282(21):15709-16. PubMed ID: 17412689
    [Abstract] [Full Text] [Related]

  • 16. [Molecular mechanism of membrane pore formation with cholesterol binding cytolysin: streptolysin O and perfringolysin O].
    Shimizu T, Hayashi H.
    Tanpakushitsu Kakusan Koso; 2001 Mar 25; 46(4 Suppl):532-9. PubMed ID: 11268657
    [No Abstract] [Full Text] [Related]

  • 17. A cell membrane modification technique using domain 4 of intermedilysin for immunotherapy against cancer.
    Nagamune H, Ohkura K, Umezu K, Shouji H, Kourai H.
    Anticancer Res; 2004 Mar 25; 24(5C):3367-72. PubMed ID: 15515433
    [Abstract] [Full Text] [Related]

  • 18. Crystallization and preliminary X-ray analysis of the human-specific toxin intermedilysin.
    Polekhina G, Giddings KS, Tweten RK, Parker MW.
    Acta Crystallogr D Biol Crystallogr; 2004 Feb 25; 60(Pt 2):347-9. PubMed ID: 14747721
    [Abstract] [Full Text] [Related]

  • 19. Aerolysin--a paradigm for membrane insertion of beta-sheet protein toxins?
    Rossjohn J, Feil SC, McKinstry WJ, Tsernoglou D, van der Goot G, Buckley JT, Parker MW.
    J Struct Biol; 1998 Feb 25; 121(2):92-100. PubMed ID: 9615432
    [Abstract] [Full Text] [Related]

  • 20. The diversity of receptor recognition in cholesterol-dependent cytolysins.
    Tabata A, Ohkura K, Ohkubo Y, Tomoyasu T, Ohkuni H, Whiley RA, Nagamune H.
    Microbiol Immunol; 2014 Mar 25; 58(3):155-71. PubMed ID: 24401114
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.